365 related articles for article (PubMed ID: 24792621)
1. Leukocyte chemotactic factor 2 amyloidosis cannot be reliably diagnosed by immunohistochemical staining.
Paueksakon P; Fogo AB; Sethi S
Hum Pathol; 2014 Jul; 45(7):1445-50. PubMed ID: 24792621
[TBL] [Abstract][Full Text] [Related]
2. Globular hepatic amyloid is highly sensitive and specific for LECT2 amyloidosis.
Chandan VS; Shah SS; Lam-Himlin DM; Petris GD; Mereuta OM; Dogan A; Torbenson MS; Wu TT
Am J Surg Pathol; 2015 Apr; 39(4):558-64. PubMed ID: 25602789
[TBL] [Abstract][Full Text] [Related]
3. Pathology and diagnosis of renal non-AL amyloidosis.
Sethi S; Theis JD
J Nephrol; 2018 Jun; 31(3):343-350. PubMed ID: 28828707
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and origin of amyloid in kidney biopsies.
von Hutten H; Mihatsch M; Lobeck H; Rudolph B; Eriksson M; Röcken C
Am J Surg Pathol; 2009 Aug; 33(8):1198-205. PubMed ID: 19561448
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte chemotactic factor 2 (LECT2)-associated renal amyloidosis: a case series.
Murphy CL; Wang S; Kestler D; Larsen C; Benson D; Weiss DT; Solomon A
Am J Kidney Dis; 2010 Dec; 56(6):1100-7. PubMed ID: 20951486
[TBL] [Abstract][Full Text] [Related]
6. The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis.
Nasr SH; Said SM; Valeri AM; Sethi S; Fidler ME; Cornell LD; Gertz MA; Dispenzieri A; Buadi FK; Vrana JA; Theis JD; Dogan A; Leung N
Kidney Int; 2013 Mar; 83(3):463-70. PubMed ID: 23302715
[TBL] [Abstract][Full Text] [Related]
7. Renal LECT2 amyloidosis: a newly described disorder gaining greater recognition.
Kowalski A; Cabrera J; Nasr S; Lerma E
Clin Nephrol; 2015 Oct; 84(4):236-40. PubMed ID: 26308079
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of transforming growth factor beta-1 in AA and AL renal amyloidosis.
Danilewicz M; Wagrowska-Danilewicz M
Pol J Pathol; 2006; 57(4):193-8. PubMed ID: 17285762
[TBL] [Abstract][Full Text] [Related]
9. Renal leukocyte chemotactic factor 2 (LECT2) amyloidosis in First Nations people in Northern British Columbia, Canada: a report of 4 cases.
Hutton HL; DeMarco ML; Magil AB; Taylor P
Am J Kidney Dis; 2014 Nov; 64(5):790-2. PubMed ID: 25064673
[TBL] [Abstract][Full Text] [Related]
10. Clinical, morphologic, and genetic features of renal leukocyte chemotactic factor 2 amyloidosis.
Larsen CP; Kossmann RJ; Beggs ML; Solomon A; Walker PD
Kidney Int; 2014 Aug; 86(2):378-82. PubMed ID: 24522497
[TBL] [Abstract][Full Text] [Related]
11. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.
Safadi S; Saad A; Quint PS; Sethi S; Leung N; Kurtin P; Nasr SH
Nephrol Dial Transplant; 2015 Jul; 30(7):1151-5. PubMed ID: 25796445
[TBL] [Abstract][Full Text] [Related]
12. Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases.
Said SM; Sethi S; Valeri AM; Leung N; Cornell LD; Fidler ME; Herrera Hernandez L; Vrana JA; Theis JD; Quint PS; Dogan A; Nasr SH
Clin J Am Soc Nephrol; 2013 Sep; 8(9):1515-23. PubMed ID: 23704299
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue.
Klein CJ; Vrana JA; Theis JD; Dyck PJ; Dyck PJ; Spinner RJ; Mauermann ML; Bergen HR; Zeldenrust SR; Dogan A
Arch Neurol; 2011 Feb; 68(2):195-9. PubMed ID: 20937937
[TBL] [Abstract][Full Text] [Related]
14. Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis.
Sethi S; Dasari S; Amin MS; Vrana JA; Theis JD; Alexander MP; Kurtin PJ
Kidney Int; 2017 Apr; 91(4):964-971. PubMed ID: 28139293
[TBL] [Abstract][Full Text] [Related]
15. Pathology and Proteomics-Based Diagnosis of Localized Light-Chain Amyloidosis in Dogs and Cats.
Kadota A; Iwaide S; Miyazaki S; Mitsui I; Machida N; Murakami T
Vet Pathol; 2020 Sep; 57(5):658-665. PubMed ID: 32880234
[TBL] [Abstract][Full Text] [Related]
16. Imaging mass spectrometry analysis of renal amyloidosis biopsies reveals protein co-localization with amyloid deposits.
Casadonte R; Kriegsmann M; Deininger SO; Amann K; Paape R; Belau E; Suckau D; Fuchser J; Beckmann J; Becker M; Kriegsmann J
Anal Bioanal Chem; 2015 Jul; 407(18):5323-31. PubMed ID: 25935672
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Distribution in a Mexican Population.
de la Cruz Jasso MA; Mejía-Vilet JM; Del Toro-Cisneros N; Aguilar-León DE; Morales-Buenrostro LE; Herrera G; Uribe-Uribe NO
Am J Clin Pathol; 2023 Jan; 159(1):89-97. PubMed ID: 36370056
[TBL] [Abstract][Full Text] [Related]
18. Renal involvement in systemic amyloidosis--an Italian retrospective study on epidemiological and clinical data at diagnosis.
Bergesio F; Ciciani AM; Santostefano M; Brugnano R; Manganaro M; Palladini G; Di Palma AM; Gallo M; Tosi PL; Salvadori M;
Nephrol Dial Transplant; 2007 Jun; 22(6):1608-18. PubMed ID: 17395661
[TBL] [Abstract][Full Text] [Related]
19. LECT2 Amyloidosis in Kidney Transplantation: A Report of 5 Cases.
Mejia-Vilet JM; Cárdenas-Mastrascusa LR; Palacios-Cebreros EJ; Reyes-Macedo M; Portilla-Jiménez A; Morales-Buenrostro LE; Cohen-Bucay A; Niño-Cruz JA; Uribe-Uribe NO
Am J Kidney Dis; 2019 Oct; 74(4):563-566. PubMed ID: 31155323
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte cell-derived chemotaxin 2 (LECT2)-associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States.
Mereuta OM; Theis JD; Vrana JA; Law ME; Grogg KL; Dasari S; Chandan VS; Wu TT; Jimenez-Zepeda VH; Fonseca R; Dispenzieri A; Kurtin PJ; Dogan A
Blood; 2014 Mar; 123(10):1479-82. PubMed ID: 24415538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
